Life Sciences
Recent studies by R. Mehrotra and co-authors add new data to life sciences findings
Published in Clinical Trials Week, October 13th, 2008
"This phase IIIb trial assessed the efficacy of increased dosages (3000 to 4500 mg/d) of reformulated lanthanum carbonate (500-, 750-, and 1000-mg tablets) in nonresponders to dosages of up to 3000 mg/d. & measurements: This 8-wk study with a 4-mo open-label extension enrolled 513 patients who were undergoing maintenance hemodiaiysis. Patients who achieved serum phosphorus control at week 4 with:53000 mg/d lanthanum...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2008-10-13)
More Articles from Clinical Trials Week
- New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
HIV drug maraviroc effective for drug-resistant patients - Sciele Pharma, Inc.
Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation - Cancer
Research from Royal Marsden Hospital yields new findings on cancer - Cancer Vaccines
Reports from Stanford University describe recent advances in cancer vaccines - Carcinoma
New research on carcinoma from T. Andre and co-authors summarized - Chemotherapy
New findings from L.J. Swinnen and co-authors describe advances in chemotherapy - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
